Invention Grant
US09382218B2 N-heteroaryl substituted aniline derivatives as HCV-antivirals
有权
N-杂芳基取代的苯胺衍生物作为HCV-抗病毒剂
- Patent Title: N-heteroaryl substituted aniline derivatives as HCV-antivirals
- Patent Title (中): N-杂芳基取代的苯胺衍生物作为HCV-抗病毒剂
-
Application No.: US14768881Application Date: 2014-02-27
-
Publication No.: US09382218B2Publication Date: 2016-07-05
- Inventor: Jean-Marc Plancher , Robert James Weikert
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Nutley
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Nutley
- International Application: PCT/EP2014/053781 WO 20140227
- International Announcement: WO2014/135423 WO 20140912
- Main IPC: C07D271/07
- IPC: C07D271/07 ; C07D263/48 ; C07D271/113 ; C07D231/38 ; C07D263/40 ; C07D271/06 ; A61K31/415 ; A61K31/4245 ; A61K45/06
Abstract:
The present invention discloses compounds of Formula (I): wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the prevention or treatment of HCV infection.
Public/Granted literature
- US20160000763A1 N-HETEROARYL SUBSTITUTED ANILINE DERIVATIVES AS HCV-ANTIVIRALS Public/Granted day:2016-01-07
Information query
